Tafenoquine Combinations for Improved Radical Cure Efficacy of Plasmodium Vivax

NCT07533136 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

300

Enrollment

FED

Sponsor class

Conditions

Uncomplicated P. Vivax Mono-infection

Interventions

DRUG: Tafenoquine (TQ)
DRUG: Chloroquine (CQ)
DRUG: Dihydroartemisinin-piperaquine (DHA-PPQ)
DRUG: Artemether-lumefantrine (AL)

Sponsor

Walter Reed Army Institute of Research (WRAIR)